FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/24/2025
Back to search
Official data from USPTO
EXANDRA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
04/03/2026
Trademark type
Combined
Nice classes
9, 42, 44
Filing date
07/06/2023
Registration date
12/03/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/03/2024
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
DE
Examiner
HUTCHISON, DAVID A
Law office
N50
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the word "EXANDRA", with a capital "E", in black stylized font and a design to the left comprised of four three-sided curved geometric shapes, arranged pointed inward in a two by two color presentation as follows: top left is red, top right is green, bottom left is blue, bottom right is pink.
Holders and representatives
Holders
Boehringer Ingelheim International GmbH
Representatives
Max Moskowitz OSTROLENK FABER LLP
Technical classification
Nice Classes
Class 9Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Downloadable computer software and downloadable mobile applications for physicians and healthcare practitioners to support clinical decision and to receive personalized therapeutic recommendations
Class 42
Design and development of software for use with medical technology; design and development of software for the collection and analysis of data
Class 44
Therapeutic servicestreatment planning for patients with diabetes; providing medical information; medical advisory services
Publications
History of USPTO decisions and trademark events.
25 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/05/2025
FIMP
FINAL DISPOSITION PROCESSED
05/05/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
03/14/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/03/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/27/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
02/27/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/03/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
12/03/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/01/2024
PUBO
PUBLISHED FOR OPPOSITION
10/01/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/11/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/28/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/27/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/27/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/27/2024
RFNT
REFUSAL PROCESSED BY IB
04/24/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/29/2024
RFRR
REFUSAL PROCESSED BY MPU
03/29/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/10/2024
CNRT
NON-FINAL ACTION WRITTEN
03/09/2024
DOCK
ASSIGNED TO EXAMINER
03/09/2024
MAFR
APPLICATION FILING RECEIPT MAILED
10/03/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/29/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/28/2023
Continuous trademark protection
Get notified about every new filing that threatens EXANDRA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.